CTX-M-3 Extended-spectrum ß-lactamase in a Shigella sonnei Clinical Isolate: First Report from Turkey
- 1 January 2003
- journal article
- case report
- Published by Taylor & Francis Ltd in Scandinavian Journal of Infectious Diseases
- Vol. 35 (8), 503-505
- https://doi.org/10.1080/00365540310013270
Abstract
A Shigella sonnei strain resistant to cefotaxime and aztreonam (but not ceftazidime) was isolated from the stool sample of a 7-y-old outpatient. Double disk synergy test, isoelectric focusing, polymerase chain reaction and sequence analysis confirmed that the isolate produced CTX-M-3, an extended-spectrum beta-lactamase (ESBL). This is the first report from Turkey of Shigella spp. producing an ESBL, and of CTX-M type enzyme.Keywords
This publication has 7 references indexed in Scilit:
- Extended-Spectrum β-Lactamases in the 21st Century: Characterization, Epidemiology, and Detection of This Important Resistance ThreatClinical Microbiology Reviews, 2001
- SHV-type extended-spectrum -lactamase in a Shigella flexneri clinical isolateJournal of Antimicrobial Chemotherapy, 2001
- Antibiotic Resistance Trends in Enteropathogenic Bacteria Isolated in 1985–1987 and 1995–1998 in BarcelonaAntimicrobial Agents and Chemotherapy, 2000
- Molecular Characterization of the SHV-11 β-Lactamase of Shigella dysenteriaeAntimicrobial Agents and Chemotherapy, 1999
- Cefotaxime-Resistant Enterobacteriaceae Isolates from a Hospital in Warsaw, Poland: Identification of a New CTX-M-3 Cefotaxime-Hydrolyzing β-Lactamase That Is Closely Related to the CTX-M-1/MEN-1 EnzymeAntimicrobial Agents and Chemotherapy, 1998
- The Use of Analytical Isoelectric Focusing for Detection and Identification of -LactamasesJournal of General Microbiology, 1975
- EPISOME-MEDIATED TRANSFER OF DRUG RESISTANCE IN ENTEROBACTERIACEAE IJournal of Bacteriology, 1961